• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Exopharm

Exopharm

  • Home
  • Products
  • Partnering
  • Science
  • Resources
    • ASX Announcements
    • Investor Information
    • News & Articles
    • Careers
  • About Us
    • Our Values
    • Our Story
    • Our Team
    • Board of Directors
  • Contact

Our Team

Management

Managing Director & Founder

Ian Dixon

Chief Commercial Officer

Chris Baldwin

Chief Operating Officer

Gregor Lichtfuss

Director of Manufacturing & Development

Alison Cook

Managing Director & Founder

Ian Dixon

PhD, MBA, MAICD

Dr Ian Dixon has a PhD in biomedical engineering from Monash University, an MBA from Swinburne University and professional engineering qualifications.

Ian has been successful in translating technology challenges into valuable businesses and respected intellectual property.

Ian is a co-inventor of Exopharm’s LEAP manufacturing technology and a co-inventor of Fortrexo, part of Exopharm’s EEV pipeline.

Ian brings to Exopharm an extensive technical, commercial and entrepreneurial background.

Before founding Exopharm in 2013, Ian co-founded Cynata Inc, the owner of the Cymerus stem cell technology now being commercialised by ASX-listed clinical-stage Cynata Therapeutics Ltd (ASX:CYP).

He is also non-executive director of NYRADA Inc. (ASX:NYR), co-inventor of Nyrada PCSK9 inhibitor drug NYX-330, and founder and investor of Cardio Therapeutics Pty Ltd.

Ian was previously a founding director of Sydney-based Noxopharm Ltd (ASX:NOX) and non-executive director of Melbourne unlisted company Cell Therapies Pty Ltd.

Chief Commercial Officer

Chris Baldwin

PhD

Dr Chris Baldwin received his PhD in Chemical Engineering from the University of Cambridge, while matriculated at Trinity College. Chris joined Exopharm in November 2019, bringing a wide range of global commercial experience to the company.

Most recently, Chris was responsible for Haemonetics’ largest and most profitable business unit across Asia Pacific, with P&L responsibilities from Taiwan to Pakistan. Previously responsible for all sales and marketing in Southeast Asia, Chris provided strategy leadership across Asia Pacific, including China.

Chris’ strategic focus and approach to management comes from his time at McKinsey and Company, where he served banking, pharmaceutical and NGO clients.

Healthcare became the focus of Chris’ career at New York Blood Center, where he was Executive Director for 8 years and responsible for the blood supply across the greater New York metropolitan area.

Chief Operating Officer

Gregor Lichtfuss

MSc, DTMPH

Dr Gregor Lichtfuss holds a PhD in Medicine / clinical immunology from Monash University, a Master of Science in International Health from Humboldt University Berlin and a Diploma in Biologie (Virology and Genetics) from Humboldt University Berlin. Gregor is a co-inventor of the LEAP Technology.

Gregor brings significant entrepreneurial experience in creating biotechnology startups and health solutions, in-depth experience and knowledge in molecular science and technology as well as an understanding of international health systems and early-stage drug development.

Gregor worked in early-stage research commercialisation at the Spinnovator, the startup creation hub managed by Ascenion GmbH, where he was instrumental in laying the business foundation for Cardior Pharmaceuticals GmbH, a biotechnology company developing novel treatments for heart failure. He has also worked as a consultant to Brandon Capital Partners in Melbourne.

Director of Manufacturing & Development

Alison Cook

MSc

Alison Cook has more than 30 years of management and leadership experience across the biopharmaceutical, diagnostic and health service sectors. She has held senior Operations Management and General Management roles across several divisions of CSL Ltd during the 13 years she was with the company, including flu vaccine and antivenom manufacture. Executive roles as COO and then CEO of Genetic Technologies Ltd and consulting in manufacturing operations, strategy and quality to biotechnology companies across Asia Pacific with Centre for Biopharmaceutical Excellence (CBE) have extended her experience.

Alison is Director at Centre for Biopharmaceutical Excellence Pty Ltd and Non-Executive Director at McPherson Ltd.


The Team

AllBusiness DevelopmentCorporateInnovationOperationsProcess DevelopmentProduct DevelopmentProduct Evaluation

Aislinn Treloar

Business Development

Alex Hall

PROCESS DEVELOPMENT

Anabel Silva

Product Development

Andrew Coley

Innovation

Angus Tester

Product Evaluation

Azita Nan Tie

BUSINESS DEVELOPMENT

Balarka Banerjee

Process Development

Ben Wade

INNOVATION

Chantelle Blyth

Process Development

Fairley McPherson

Product Evaluation

Hansi Ranasinghe

PRODUCT EVALUATION

Ivan Jasenko

CORPORATE

Jancy Johnson

Product Evaluation

Johannes Weber

PROCESS DEVELOPMENT

Joseph Lee

PROCESS DEVELOPMENT

Julia Loseff-Silver

INNOVATION

Karen Holden

INNOVATION

Karmen Kong

Product Development

Kartini Asari

INNOVATION

Katarzyna Somszor

BUSINESS DEVELOPMENT

Lieven Huang

Business Development

Mehak Bhola

BUSINESS DEVELOPMENT

Melanie Schoppet

Product Development

Melissa Lim Beng Lee

Innovation

Michael Temopoulos

Operations

Mozhgan Shojaee

Product Evaluation

Mun Joo Chuei

PRODUCT DEVELOPMENT

Nenad Sejic

INNOVATION

Owen Tatford

Process Development

Patrick James

Product Development

Ramin Khanabdali

Process Development

Ranja Salvamoser

Innovation

Sadman Bhuiyan

Process Development

Sam Keenan

INNOVATION

Sam Law

Process Development

Thien Dinh

OPERATIONS

Wil Lehmann

Product Development

Yiqin Zhu

CORPORATE

Footer

Resources

  • ASX Announcements
  • Investor Information
  • Board of Directors
  • News & Articles

Information

  • Contact
  • Partnering
  • Join Our Mailing List
  • Privacy, Terms and Conditions
  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo
Copyright © 2021 · Exopharm · ACN 163 765 991 · info@exopharm.com
Level 17/31 Queen St, Melbourne VIC Australia 3000 · P: +61 (0)3 9111 0026 ·

Web Design by Mallee Blue Media